F6777

Flecainide acetate salt

≥98% (TLC), powder, sodium channel blocker

• Synonym(s): N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt
• Empirical Formula (Hill Notation): C₁₇H₂₀F₆N₂O₃ · C₂H₄O₂
• CAS Number: 54143-56-5
• Molecular Weight: 474.39
• EC Number: 258-997-5
• MDL number: MFCD00214290
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278440
• NACRES: NA.77

Properties

• product name: Flecainide acetate salt,
• Quality Level: 200
• originator: Medicis
• storage temp.: 2-8°C
• SMILES string: CC(O)=O.FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2
• InChI: 1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)
• InChI key: RKXNZRPQSOPPRN-UHFFFAOYSA-N
• Gene Information: human ... SCN5A(6331)

Description

Biochem/physiol Actions

Class IC antiarrhythmic agent; sodium channel blocker

Features and Benefits

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Medicis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Danger
• Hazard Statements: H302,H315,H319,H335,H360FD
• Precautionary Statements: P202 - P261 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT SE 3
• Target Organs: Respiratory system
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable